Glaukos Corporation [GKOS] stock is trading at $116.22, up 2.66%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GKOS shares have gain 6.74% over the last week, with a monthly amount glided 20.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Glaukos Corporation [NYSE: GKOS] stock has seen the most recent analyst activity on October 27, 2025, when Wells Fargo upgraded its rating to a Overweight but kept the price target unchanged to $120 for it. Previously, Goldman started tracking the stock with Buy rating on October 01, 2025, and set its price target to $103. On May 01, 2025, downgrade downgraded it’s rating to Equal Weight but maintained its price target of $86 on the stock. Mizuho upgraded its rating to a Outperform and increased its price target to $200 on February 19, 2025. Citigroup upgraded its rating to a Buy and raised its price target to $162 on December 11, 2024. UBS started tracking with a Buy rating for this stock on December 06, 2024, and assigned it a price target of $182. In a note dated December 02, 2024, Morgan Stanley downgraded an Underweight rating on this stock but restated the target price of $120.
Glaukos Corporation [GKOS] stock has fluctuated between $73.16 and $163.71 over the past year. Currently, Wall Street analysts expect the stock to reach $120.22 within the next 12 months. Glaukos Corporation [NYSE: GKOS] shares were valued at $116.22 at the most recent close of the market. An investor can expect a potential return of 3.44% based on the average GKOS price forecast.
Analyzing the GKOS fundamentals
Glaukos Corporation [NYSE:GKOS] reported sales of 469.82M for the trailing twelve months, which represents a growth of 38.14%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -0.19%, Pretax Profit Margin comes in at -0.19%, and Net Profit Margin reading is -0.19%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.11 and Total Capital is -0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 113.80 points at the first support level, and at 111.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 117.51, and for the 2nd resistance point, it is at 118.80.
Ratios To Look Out For
For context, Glaukos Corporation’s Current Ratio is 5.20. In addition, the Quick Ratio stands at 4.47 and the Cash Ratio stands at 1.12. Considering the valuation of this stock, the price to sales ratio is 14.21, the price to book ratio is 8.67.
Transactions by insiders
Recent insider trading involved Kliman Gilbert H, Director, that happened on Dec 09 ’25 when 5000.0 shares were sold. Director, Kliman Gilbert H completed a deal on Dec 09 ’25 to buy 5000.0 shares. Meanwhile, SVP & CHIEF FINANCIAL OFFICER Thurman Alex R. sold 315.0 shares on Nov 25 ’25.
